Match Document Document Title
5646131 Method for solubilizing drugs using cyclodextrins and carboxylic acids  
A method for enhancing the solubilization and/or complexation of a drug which is insoluble or sparingly soluble in water with cyclodextrin, comprising combining the drug with cyclodextrin together...
5637575 Methods of inhibiting restenosis  
Disclosed are compositions and methods effective for inhibiting restenosis. In particular, the present invention provides compositions for inhibiting undesired smooth muscle cell growth or...
5631244 mono(6-amino-6-deoxy)cyclodextrin derivatives substituted in the 6-position by an α-amino acid residue, process for their preparation and their uses  
Mono (6-amino-6-deoxy)cyclodextrin derivatives substituted in the 6-position by an α-amino acid residue. These derivatives correspond to the following general formula: ##STR1## in which: CD...
5629299 Hydrolytic stabilizer for unstable organic ions  
Storage-stable aqueous solutions of hydrolytically unstable organic ionic compounds and cyclodextrins, which cyclodextrins are capable of forming hydrolytically stable inclusion complexes with the...
5624914 Lipophilic oligosaccharide antibiotic salt compositions  
Pharmaceutically acceptable compositions of matter comprising a lipophilic oligosaccharide antibiotic, e.g., the everninomicin-type antibiotic of Formula III, at least a stoichiometric amount of a...
5624907 Beverage for preoperative intake  
A beverage for preoperative use is disclosed which comprises a hypotonic aqueous solution of a carbohydrate mixture consisting of at least one member from each of the groups, mono-, di-, and...
5620964 Compositions for treating and inhibiting gastric and duodenal ulcers  
A composition for treating and/or inhibiting gastric and duodenal ulcers, comprising an oligosaccharide selected from the group consisting of Formula I ##STR1## or a mixture thereof; wherein: X...
5620961 Fructose ester-β-cyclodextrin complexes and processes for making and using same  
A specialized derivative of fructose in which the compound is a fructose ester complexed with β-cyclodextrin. Preferably, the fructose derivative is fructosehexanoate β-cyclodextrin complex, and...
5614167 Test patch and its use for demonstrating contact allergy  
5612321 Antioxidant grafted polysaccharides  
Grafted polysaccharide compositions comprising polysaccharides grafted with antioxidants on at least one hydroxyl group of the polysaccharide. The use of antioxidant grafted polysaccharides or...
5605892 Compositions of arginine amide with cyclodextrin of caffeine, and methods of use  
An aqueous agent comprising at least one arginine amide selected from the group consisting of (2R,4R)-4-methyl-1-[N 2 -((RS)-3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-ar ginyl]-2-piper...
5593978 Growth promoting composition for fish and method of using the same  
A method for promoting growth in fish comprising administering a low level dosage amount of zearalanol to fish. The zearalanol may be conveniently administered to the fish via a novel fish feed...
5591725 Water-in-oil dispersion  
The present invention is concerned with a plastic dispersion containing from 5-65 wt. % of a continuous fat phase and from 95-35 wt. % of a gelling polysaccharide containing dispersed aqueous...
5587399 Method for preparing medical foods for the nutritional support of infants/toddlers with metabolic diseases  
The present invention involves a method of preparing a nutritional product in which a powder base containing fats, carbohydrates, vitamins, minerals and trace elements is mixed with specific amino...
5578585 Pleuromutilin derivative complexes  
Complexes and pharmaceutical preparations containing complexes of the pleuromutilin derivative of formula I ##STR1## in free base or in acid addition or quaternary salt form and cyclodextrin are...
5573773 Stable highly concentrated formulations of fluorescein derivatives  
The present invention relates to stable highly concentrated formulations of specific fluorescein derivatives, to the preparation of said formulations and the use thereof, especially for the...
5574019 Method of perfusing a primate  
The present invention relates to the field of compositions of matter, disclosing compositions of matter which as aqueous solutions, may be used to perfuse a living or non-living subject in need of...
5562921 Stable solid pharmaceutical compositions containing enalapril maleate  
Enalapril maleate is unstable when associated with many excipients commonly used in the manufacture of pharmaceutical compositions. Stable solid compositions are provided by mixing enalapril...
5561116 Solid product containing propolis components, and preparation and uses thereof  
A solid, water-dispersible composition containing propolis components. This composition is prepared by extracting intact or dewaxed propolis with an aqueous solution of a water-soluble organic...
5541202 New leukotriene-B4 Antagonists and their use as pharmaceutical agents  
1. Leukotriene-B 4 antagonists of formula I, ##STR1## are described, in which X represents C 1 -C 4 -alkoxy or --S(O) p --(C 1 -C 4 )-alkyl, p represents 0, 1 or 2 Y represents a hydrogen atom...
5529915 Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin  
Disclosed are lyophilized biologically active proteinaceous compositions containing low diol polyalkylene oxide, such as polyethylene glycol, covalently attached to a biologically active...
5527783 Dry and Porous galenic form based on plants, its method of preparation and its applications  
Solid compositions based on plants, capable of being converted to a dry and porous galenic form (lyophilized or equivalent form) which is undivided or powdered. Said dry and porous galenic form...
5525596 Absorption enhancer/solubilizer combination for improved bioavailability of a zwitterionic compound  
Intestional absorption of zwitterionic compounds is enhanced when the compound is delivered with the absorption enhancer palmitoyl carnitine chloride and the solubilizing agent β-cyclodextrin when...
5519011 Food composite performing function of improving serum lipid  
A method for decreasing a content of lipid and total cholesterol in serum and increasing a relative content of HDL cholesterol in serum which comprises the steps: (a) providing a pyrodextrin...
5519012 Inclusion complexes of optically active 1,4-dihydropyridines with methyl-β-cyclodextrin  
Novel inclusion complexes of racemic 1,4-dihydropyridines and enantiomers thereof of the formula ##STR1## wherein R represents a phenyl group, substituted with nitro, trifluoromethyl,...
5516766 Cyclodextrin polymers and cyclodextrins immobilized on a solid surface  
Polyionic derivatives of cyclodextrin polymers and cyclodextrins immobilized on a solid surface are disclosed. Compositions and methods for separating a molecular species, including but not limited...
5514665 Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans  
Methods for reducing the risk of or preventing infections by bacterial pathogens in vivo. In particular, a method for reducing the risk of P. aeruginosa infection in vivo in compromised hosts such...
5514668 Composition for removing or inactivating harmful components in blood or other extracellular body fluids  
A composition for removing or inactivating harmful components including virus from blood or other extracellular liquids comprises a crown ether compound substituted on a polysaccharide, preferably...
5512290 Compositions containing 2-acetyl-1-pyrroline  
A powder-form composition of 2-acetyl-1-pyrroline incorporated with a support of maltodextrin and/or cyclodextrin. The composition is prepared by hydrolyzing a 2-(1-alkoxyethenyl)-1-pyrroline with...
5506216 Cyclodextrin-biocide complex  
The invention concerns a complex of cyclodextrin and an organic biocide, wherein the organic biocide has a maximum water-solubility of 0.15% (w/v) at a temperature of 25° C., a process for the...
5498408 Oral rehydration composition  
The invention relates to an oral rehydration formula containing a conventional carbohydrate, rice flour and carrot powder as carbohydrate sources.
5494901 Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent  
A topical composition comprising an amount of a carbonic anhydrase inhibitor and an amount of β-cyclodextrin derivative effective in increasing the bioavailability of the carbonic anhydrase...
5490978 Block copolymers of polysaccharides and polyalkylene oxides  
Polysaccharides (e.g., dextran) of different molecular weights were substituted at the anomeric carbon with polyalkylene oxides of different molecular weights to give novel diblock copolymers. The...
5486508 Cyclodextrin composition  
A pharmaceutical composition comprising a slightly water-soluble drug, a cyclodextrin and a water-soluble organic solvent is disclosed. The composition improves water-solubility and stability of...
5484777 Pancreatic cholesterol esterase inhibitor  
This invention encompasses a method and compositions which inhibit pancreatic cholesterol esterase and triglyceride lipase and hence, lower cholesterol and triglycerides in the blood stream.
5484776 Process for the production of stable liquid form of beta-blocker-containing medicaments with controlled release of the active constituent for oral administration  
This invention relates to a process for the production of optimally stable orally administrable solution forms of medicaments containing high-molecular polysaccharides, with controlled release of...
5476852 Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin  
A method of topically treating subjects suffering from acne, hyperkeratotic dermatoses and photo-aging of the skin, by administering to the skin of said subjects an effective amount of the...
5472954 Cyclodextrin complexation  
The invention provides a method for enhancing the complexation of a cyclodextrin with a lipophilic and/or water-labile active ingredient which is a drug, cosmetic additive, food additive or...
5464827 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors  
This invention relates esterified polysulfated cyclodextrins, their use in treating diseases and conditions which are characterized by excessive smooth muscle cell (SMC) proliferation such as...
5455236 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds  
The invention relates to novel cyclodextrin inclusion compounds of 5,10-methylenetetrahydrofolic acid. The surprisingly good stability of these compounds makes possible their pharmaceutical use for...
5447920 Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin  
A cosmetic composition comprising an inclusion product having a slightly water-soluble component with a hydroxyalkylated cyclodextrin formulated therein.
5441944 Substituted cyclodextrin sulfates and their uses as growth modulating agents  
The invention relates to highly water soluble substituted α-, β- or γ-cyclodextrin sulfates associated with a physiologically acceptable cation. Pathological or otherwise undesirable cell or...
5439894 Dextrin derivatives for the treatment of acidic conditions  
Disclosed is a pharmaceutical composition comprising a dextrin derivative in which a proportion of the hydroxyl groups of dextrin are replaced by basic groups. Such compositions are useful for the...
5431925 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression  
Disclosed is a nutritive composition for patients being treated with anticancer drugs, which comprises 1-5 mg weight % of a retinoid compound in the solid content of the composition composed of...
5422347 β-cyclodextrin complexes of miconazole and econazole  
The econazole and miconazole complexes with β-cyclodextrin show in vitro a good anti-fungal activity with a wide spectrum and, if locally applied, are well tolerated and more effective than the...
5418225 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
 
A topical composition comprising an amount of a carbonic anhydrase inhibitor and an amount of β-cyclodextrin derivative effective in increasing the bioavailability of the carbonic anhydrase...
5416078 Fluid resuscitation  
The invention relates to fluid resuscitation of the human or animal body by administration of deferoxamine (DFO) and a water-soluble biopolymer. The DFO and the biopolymer are preferably bonded...
5403828 Purification of cyclodextrin complexes  
A method is provided for purifying crude inclusion complexes of cyclodextrin which is used as a host material, in combination with a guest material, such as light mineral oil. After the crude...
5391545 Combating of undesired organisms  
Undesired organisms, including insects, mites and fungi, may be combated by application of a liquid composition which comprises starch dextrin or an analogous derivative of amylopectin as an active...
5385891 Polysulfate of β-cyclodextrin derivative and process for preparing the same  
Disclosed is a polysulfate of a β-cyclodextrin in which at least one of 7 D-glucose units constituting the β-cyclodextrin is a unit represented by the formula (I-a): ##STR1## wherein R 1 is an...